From Science Week: Innovative arenas create collaboration for the city of the future

In a panel discussion during Science Week on February 1, it was discussed how innovative neutral arenas are central to the development of the smart and knowledge-intensive city.

Flemingsberg Science CEO Johnny Högberg participated together with a panel consisting of Sophia Sundberg, CEO, Barkaby Science, Peter Dobers, Professor of Business Administration with a focus on sustainable development and collaboration, Södertörn University, Johan Zachrisson, Business Development Manager, Fabege and Anton Västberg, Development Director, Region Stockholm. All under the guidance of moderator Lydia Capolicchio.

Watch on Youtube.

Published On: 2 February 2023

  • He has built up Sweden’s leading gene and cell therapy lab

    I drygt 20 år har Pontus Blomberg styrt stegen mot Vecura i Flemingsberg. Här har han tillsammans med sina medarbetare byggt upp Sveriges främsta labb inom gen- och cellterapi. Ett område som kan leda till botande behandlingar för såväl olika cancersjukdomar som Alzheimers.

  • Cecilia Bergh: “We’ll succeed – it just needs hard work”

    After almost 25 years’ concerted struggle to disseminate her successful eating disorder treatment, Cecilia Bergh wants to shift up a gear. Her goal is to digitalise her technique and turn the Mandometer support tool into a consumer product.

  • Chris Heister: “Everyone who has made this journey feels as though they’re fighting the system a bit.”

    Even if Chris Heister shifts down a gear when she leaves her role as council leader in Stockholm, she is unlikely be drawing on her pension any time soon. The class journey she has made from growing up in a countryside idyll, north of Stockholm, has given her a momentum that continually drives her forward.

  • Evren Alici set to make cancer a liveable illness

    A recent study could pave the way to treating a type of bone marrow cancer. The aim is to transform the cancer from being incurable to a disease that it is possible to live with. The research behind the study was conducted in Evren Alici’s group at Campus Flemingsberg.

  • Karin Mellström: “Co-operation is the key to success”

    After 10 years as a start-up, CellProtect Nordic Pharmaceuticals has taken a major step forward. Our patient and careful work is now bearing fruit, explains Karin Mellström, CEO and founder. Looking back on her career, she sums it up by saying: “I’d never been bored for a second!”